Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Targeted radiation to liver tumors spares tissue, improves quality of life

12.11.2002


Radioactive spheres delivered via blood flow to tumor



Vanderbilt University Medical Center is offering the latest advancement for treating inoperable liver tumors.

Selective Internal Radiation Therapy (SIRT) targets a very high radiation dose to tumors within the liver, regardless of their cell of origin, number, size or location. The procedure uses biocompatible radioactive microspheres (SIR-Spheres®) that contain yttrium-90 and emit high energy beta radiation.


"The liver doesn’t tolerate external beam radiation in sufficient doses to affect tumor without damaging the remaining good liver," said Dr. C. Wright Pinson, H. William Scott Jr. Professor of Surgery and chair of the department. "These spheres emit radiation for a short distance, less than a centimeter. If you can cluster radiation right around the tumor, the radiation exposure at the tumor site compared to normal liver is favorable."

The spheres are implanted using a catheter placed in the artery feeding the liver and travel via the blood stream, where the spheres are targeted to the tumors within the liver. The spheres are trapped in the small blood vessels of the tumor (doctors do not have to identify the number or location of tumors, since the spheres target the cancerous growth in the liver) where they destroy the tumor without affecting most of the normal liver tissue.

In the procedure, an interventional radiologist selectively catheterizes the arteries feeding the tumor and monitors the catheter during administration of the dose. A nuclear medicine scan is done before the spheres are administered to assure that the catheter is correctly positioned and that the tumors will be properly targeted.

The patient stays overnight and is discharged the next day. "The early reports describe enhanced survival rate," said Pinson, who expects as many as 50 patients could be offered the therapy within the next year at VUMC.

A randomized trial in patients with colorectal liver metastases conducted by Sirtex, the manufacturer, showed the median survival rate doubled from 12.8 months with chemotherapy alone to 27.1 months with SIRT and chemotherapy. SIRT is another means of attack in the battle against liver cancer. "This is not a cure. It’s a prolongation of life and an improvement of survival and quality of life," said Dr. Bill Martin, associate professor of Radiology and Radiological Sciences at Vanderbilt. However, unlike many cancer therapies, side effects are minimal.

"For the patient, it’s a one-time deal and they feel relatively fine afterwards. We don’t do too many procedures like that."

Many patients experience a post-procedural fever that starts immediately after implantation of the spheres and can last from a few days to a week. The fever is usually nocturnal and is likely related to the embolic effect of the microspheres and the acute radiation effects on the tumor. Some patients experience significant abdominal pain immediately after the procedure and may need pain relief with narcotic analgesia, but the pain generally subsides within an hour. Some patients will experience nausea that may require anti-emetic medication. The therapy has been used to treat hundreds of patients with liver cancer in Australia, New Zealand, Hong Kong, Singapore and Thailand. and more recently in the United States in a variety of clinical trials and in general practice.

Clinton Colmenares | EurekAlert!
Further information:
http://www.mc.vanderbilt.edu/reporter/

More articles from Health and Medicine:

nachricht Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University

nachricht Direct conversion of non-neuronal cells into nerve cells
03.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Subaru Telescope helps pinpoint origin of ultra-high energy neutrino

16.07.2018 | Physics and Astronomy

Barium ruthenate: A high-yield, easy-to-handle perovskite catalyst for the oxidation of sulfides

16.07.2018 | Life Sciences

New research calculates capacity of North American forests to sequester carbon

16.07.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>